Thermo Fisher Scientific Inc.
TMOLast close · Oct 16, 2026690.00−6.49 (−0.93%)
Market cap$255.1B
Key indicators
Revenue46.3B+7.2% on a year earlier
24.4B
25.5B
32.2B
39.2B
44.9B
42.9B
42.9B
44.6B
46.3B
47.9B
50.4B
53.5B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 24.4B | 25.5B+4.9% | 32.2B+26.1% | 39.2B+21.7% | 44.9B+14.5% | 42.9B−4.6% | 42.9B+0.1% | 44.6B+3.9% | 46.3B+7.2% | 47.9B | 50.4B | 53.5B | |
| — | 4.9% | 26.1% | 21.7% | 14.5% | -4.6% | 0.1% | 3.9% | 7.2% | 7.5% | 5.2% | 6.3% | |
| $7.24 | $9.17+26.7% | $15.96+74.0% | $19.46+21.9% | $17.63−9.4% | $15.45−12.4% | $16.53+7.0% | $17.74+7.3% | $18.59+7.6% | $25.14 | $27.49 | $30.34 | |
| Profitability | ||||||||||||
| 15.5% | 18.0%+2.5 pt | 24.2%+6.2 pt | 25.6%+1.4 pt | 18.7%−6.9 pt | 16.0%−2.7 pt | 17.1%+1.1 pt | 17.4%+0.3 pt | 17.6%+0.4 pt | · | · | · | |
| — | 14.5% | 19.8%+5.3 pt | 19.7%−0.1 pt | 15.5%−4.2 pt | 14.0%−1.5 pt | 14.8%+0.8 pt | 15.0%+0.3 pt | 15.0%−0.2 pt | · | · | · | |
| — | 12.5% | 18.5%+6.0 pt | 18.9%+0.5 pt | 15.8%−3.1 pt | 12.8%−3.0 pt | 12.8%−0.1 pt | 12.6%−0.2 pt | — | · | · | · | |
| Cash | ||||||||||||
| 3.8B | 4.0B+6.9% | 6.8B+68.4% | 6.8B−0.4% | 6.9B+1.8% | 6.9B+0.2% | 7.3B+4.9% | 6.3B−13.4% | 7.3B+18.6% | · | · | · | |
| 15.5% | 15.8%+0.3 pt | 21.2%+5.3 pt | 17.3%−3.8 pt | 15.4%−1.9 pt | 16.2%+0.8 pt | 16.9%+0.8 pt | 14.1%−2.8 pt | 15.8%+1.5 pt | · | · | · | |
| 266.0M | 297.0M+11.7% | 337.0M+13.5% | 395.0M+17.2% | 455.0M+15.2% | 523.0M+14.9% | 583.0M+11.5% | 636.0M+9.1% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 0.69x | 0.60x−0.09x | 0.63x+0.03x | 0.85x+0.22x | 0.78x−0.07x | 0.75x−0.04x | 0.63x−0.12x | 0.74x+0.11x | 0.81x+0.11x | · | · | · | |
| 406.00M | 403.00M−0.7% | 399.00M−1.0% | 397.00M−0.5% | 394.00M−0.8% | 388.00M−1.5% | 383.00M−1.3% | 378.00M−1.3% | 371.00M−1.9% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 27, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.